<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="19955" end="19962" sStart="19851" offset="104" sid="r8.suggest.v.0115" wn="3" wnkey="suggest%2:32:02::" text="Upregulation of CCR5 and CXCR3 on T cells and accumulation of these cells in the lung periphery suggest that aberrant, unremitting pulmonary recruitment of these activated T cells is unique to people with smoking-related lung disease, despite cessation of exposure to the inciting agent, tobacco smoke." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="15001" end="15007" sStart="null" offset="37" sid="r11.strong.j.0197" wn="1" wnkey="strong%3:00:00::" text="Together, these data indicate that a strong type 1 bias is characteristic of the T cells isolated from the peripheral lung of participants with COPD and emphysema and that this immune phenotype correlates with the lung destruction that is characteristic of this disease." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="8416" end="8422" sStart="null" offset="146" sid="r8.state.n.0137" wn="4" wnkey="state%1:14:00::" text="Phenotypic characterization of T cells was done by two-color flow cytometry (Epic XL FL, Beckman Coulter, Allendale, New Jersey, United States) using combinations of the following monclonal antibodies: FITC-conjugated anti-CD4, -CD8, and -CD14; PE- and Cy5-conjugated anti-CCR4, -CCR3, -CCR5, and -CXCR3." />
    <s path="file:/c:/OANC/data/written_2/technical/plos/pmed.0010008.anc" start="22275" end="22282" sStart="null" offset="0" sid="null" wn="3" wnkey="show%2:32:00::" text="We extend these findings by &lt;b&gt;showing&lt;/b&gt; CXCR3 expression on lung macrophages and CD4 + T cells in emphysema patients and the functional interplay between Th1-related chemokines and elastolytic MMPs." />
    <s path="file:/c:/OANC/data/written_2/technical/plos/pmed.0010008.anc" start="22275" end="22282" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="We extend these findings by &lt;b&gt;showing&lt;/b&gt; CXCR3 expression on lung macrophages and CD4 + T cells in emphysema patients and the functional interplay between Th1-related chemokines and elastolytic MMPs." />
    <s path="file:/c:/OANC/data/written_2/technical/plos/pmed.0010008.anc" start="22275" end="22282" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="We extend these findings by &lt;b&gt;showing&lt;/b&gt; CXCR3 expression on lung macrophages and CD4 + T cells in emphysema patients and the functional interplay between Th1-related chemokines and elastolytic MMPs." />
    <s path="file:/c:/OANC/data/written_2/technical/plos/pmed.0010008.anc" start="22275" end="22282" sStart="null" offset="0" sid="null" wn="3" wnkey="show%2:32:00::" text="We extend these findings by &lt;b&gt;showing&lt;/b&gt; CXCR3 expression on lung macrophages and CD4 + T cells in emphysema patients and the functional interplay between Th1-related chemokines and elastolytic MMPs." />
    <s path="file:/c:/OANC/data/written_2/technical/plos/pmed.0010008.anc" start="22275" end="22282" sStart="null" offset="0" sid="null" wn="2" wnkey="show%2:31:00::" text="We extend these findings by &lt;b&gt;showing&lt;/b&gt; CXCR3 expression on lung macrophages and CD4 + T cells in emphysema patients and the functional interplay between Th1-related chemokines and elastolytic MMPs." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="21643" end="21649" sStart="null" offset="255" sid="r11.severe.j.0634" wn="1" wnkey="severe%5:00:00:intense:00" text="Analysis by immunohistochemistry of airway mucosa of people with atopic asthma after antigen challenge revealed that large numbers of CCR4 + and CCR8 + T cells express IL-4, and CCR4 expression was prominent in people with severe atopic dermatitis, which decreased upon abatement of disease activity [26,43]." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="3210" end="3216" sStart="null" offset="128" sid="r11.severe.j.0631" wn="1" wnkey="severe%5:00:00:intense:00" text="In this study we determined the dominant T helper phenotype in lung samples from ex-smoker individuals with moderate to severe COPD and emphysema and control individuals with no evidence of smoking-related lung disease." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="4609" end="4615" sStart="null" offset="307" sid="r11.severe.j.0632" wn="1" wnkey="severe%5:00:00:intense:00" text="Twenty-eight non-atopic ex-smoker individuals (see Table 1) undergoing medically necessary lung resection were serially entered into the study: ten individuals with no COPD and no evidence of emphysema (control group) and eighteen individuals (diseased group) with moderate to severe COPD and evidence of emphysema as determined by pulmonary function tests, high-resolution computed tomography (CT), or conventional CT scan." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="20544" end="20550" sStart="null" offset="95" sid="r11.severe.j.0633" wn="5" wnkey="severe%5:00:00:critical:03" text="Additionally, lung lymphocytes isolated from four lifelong non-smoker individuals with severe obstructive lung disease due to cystic fibrosis or bronchiolitis obliterans did not show a Th1 inflammatory bias of the lung (S." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="11340" end="11351" sStart="null" offset="337" sid="r11.recommend.v.0772" wn="1" wnkey="recommend%2:32:01::" text="Paraffin-embedded, and fresh-frozen lung sections (5 ?m) were immunostained using monoclonal antibodies against human MMP12 (R&amp;D Systems) or non-immune antisera by an immunoperoxidase protocol (Vectastain Elite, Vector Labs, Burlingame, California, United States) and counterstained with hematoxylin as recommended by the manufacturer." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="4987" end="4998" sStart="null" offset="55" sid="r11.recommend.v.0771" wn="1" wnkey="recommend%2:32:01::" text="COPD was diagnosed according to the criteria recommended by the National Institutes of Health/World Health Organization workshop summary [31]." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="6380" end="6386" sStart="null" offset="233" sid="r9.normal.j.0872" wn="1" wnkey="normal%3:00:01::" text="High-resolution CT (two in emphysema group and two in control group) or conventional CT analysis was used to detect emphysema, characterized by the presence of areas of low attenuation contrasted with surrounding normal lung parenchyma [32,33]." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="22103" end="22109" sStart="null" offset="66" sid="r9.normal.j.0656" wn="1" wnkey="normal%3:00:01::" text="Furthermore, previous studies of smoker individuals with COPD and normal lung function showed the presence of CD8 + /CXCR3 + T cells in the airway epithelium and submucosa [44]." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="3600" end="3606" sStart="null" offset="282" sid="r9.normal.j.0362" wn="2" wnkey="normal%3:00:02::" text="Analysis of chemokine receptor expression on isolated peripheral lung lymphocytes from ex-smokers with COPD/emphysema indicated that both CD4 and CD8 T helper cells are strongly polarized to the Th1 phenotype compared to T cells isolated from lung tissue of normal individuals or individuals with non-smoking-related obstructive lung disease." />
    <s path="[OANC]/data/written_2/technical/plos/pmed.0010008.anc" start="13208" end="13213" sStart="null" offset="71" sid="r9.level.n.0437" wn="1" wnkey="level%1:07:00::" text="Further, both CD4 and CD8 T cells expressed CCR5 at the same level (Figure 1C)." />
  </sentences>
</list>